Albuterol Sulfate Solution
Product Images NDC 59651-183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 59651-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)
The text is a graph titled "% Change from Pre-Dose FEV, Intent-to-Treat Population". It shows the results of a treatment with albuterol (1.25mg and 0.63mg) and a placebo over time in hours. The y-axis displays percentage change and the x-axis is time in hours from pre-dose. There is no further information.*
FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)
The text describes a graph or chart titled "Figure 2" showing the "% Change from Pre-Dose FEV" of an "Intent-to-Treat Population" on day 28. The X-axis shows the "Hours from Pre-Dose" and the Y-axis shows the percentage of change from the "Pre-Dose FEV." The graph includes three treatments: "e—albuterol 1.25 mg," "eo—albuterol 0.63 mg," and "-»-e-placebo."*
FDA Label Image

Figure 1 (Albuterol Fig3)

Figure 1 (Albuterol Fig3)
FDA Label Image

Figure 2 (Albuterol Fig4)

Figure 2 (Albuterol Fig4)
FDA Label Image

Figure 3, 4 (Albuterol Fig5)

Figure 3, 4 (Albuterol Fig5)
FDA Label Image

Package Label-principal Display Panel (0.63 mg per 3 mL)

Package Label-principal Display Panel (0.63 mg per 3 mL)
This is a description of a medication called Albuterol Sulfate Inhalation Solution, which is sold in a package containing five 3 mL sterile unit-dose vials. Each vial contains 0.75 mg of Albuterol sulfate USP, along with sodium chloride, sulfuric acid (used to adjust pH to 3.5), and water for injection. The medication is stored between 2°C and 25°C and protected from light. It is intended for use in children ages 2 to 12, with the dosage noted in the accompanying prescribing information. The medication should only be used as directed by a physician and not exceed the recommended dosage. The package is distributed by Aurobindo Pharma USA and made in India.*
FDA Label Image

Package Label-principal Display Panel (0.63 mg per 3 mL – Container-Carton (25 Vials))

Package Label-principal Display Panel (0.63 mg per 3 mL – Container-Carton (25 Vials))
This is a text related to medication. It gives information about Albuterol Sulfate Inhalation Solution. The text provides details about the product such as its potency, inactive components, storage instructions, dosage, and warnings. It also advises pharmacists to give patients a patient instruction for use with each purchase.*
FDA Label Image

Package Label-principal Display Panel – 1.25 mg Per 3 mL (Pouch Label (5 Vials))

Package Label-principal Display Panel – 1.25 mg Per 3 mL (Pouch Label (5 Vials))
This is a product description for Albuterol Sulfate Inhalation Solution containing 1.25 mg of active ingredient (Albuterol sulfate USP) per 3 mL vial, intended for children ages 2 to 12 years old. The solution also contains inactive ingredients like sodium chloride, sulfuric acid, and water for infection. The vials should be stored between 2°C to 25°C and protected from light. Once removed from the foil pouch, the vials should be used within one week, and the solution should be clear. The accompanying prescribing information should be consulted before use. The product is distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (1.25 mg per 3 mL – Container-Carton (25 Vials))

Package Label-principal Display Panel (1.25 mg per 3 mL – Container-Carton (25 Vials))
This is a description of a medication called Albuterol Sulfate Inhalation Solution. The solution is packaged in sterile unit-dose vials with a potency of 1.25mg Albuterol per 3mL, which is equivalent to 1.5 mg of Albuterol Sulfate. The packaging comes with a patient's instruction for use, and each carton contains 5 pouches of five 3 mL vials each. The medication should only be used as directed by the physician, and dispensed by the pharmacist. The inactive ingredients are Sodium Chloride, Sulfuric Acid, and water for injection. The medication should be stored between 2°C to 25°C (36°F to 77°F). The usual dosage is for children ages 2 to 12. The medication is distributed by Aurobindo Pharma USA, Inc. and was made in India.*
FDA Label Image

Albuterol-str (Albuterol Str)

Albuterol-str (Albuterol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.